Australia markets close in 2 hours 30 minutes

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.30+0.27 (+3.36%)
At close: 04:00PM EDT
8.21 -0.09 (-1.08%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.28B
Enterprise value 1.54B
Trailing P/E 12.35
Forward P/E 39.53
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.19
Price/book (mrq)1.89
Enterprise value/revenue 3.15
Enterprise value/EBITDA 4.94

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-74.09%
S&P500 52-week change 3-6.14%
52-week high 333.64
52-week low 35.42
50-day moving average 38.47
200-day moving average 312.80

Share statistics

Avg vol (3-month) 31.87M
Avg vol (10-day) 33.25M
Shares outstanding 5284.54M
Implied shares outstanding 6N/A
Float 8207.07M
% held by insiders 128.65%
% held by institutions 140.26%
Shares short (28 Apr 2022) 411.72M
Short ratio (28 Apr 2022) 49.03
Short % of float (28 Apr 2022) 47.73%
Short % of shares outstanding (28 Apr 2022) 44.12%
Shares short (prior month 30 Mar 2022) 412.03M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 41.88%
Operating margin (ttm)55.47%

Management effectiveness

Return on assets (ttm)12.46%
Return on equity (ttm)18.92%

Income statement

Revenue (ttm)489.04M
Revenue per share (ttm)1.75
Quarterly revenue growth (yoy)56.20%
Gross profit (ttm)267.62M
EBITDA 286.45M
Net income avi to common (ttm)204.82M
Diluted EPS (ttm)0.64
Quarterly earnings growth (yoy)43.80%

Balance sheet

Total cash (mrq)786.05M
Total cash per share (mrq)2.76
Total debt (mrq)40.28M
Total debt/equity (mrq)3.34
Current ratio (mrq)5.50
Book value per share (mrq)4.24

Cash flow statement

Operating cash flow (ttm)235.26M
Levered free cash flow (ttm)109.25M